BioNTech/Pfizer brings forward 50 mn doses for EU to Q2 says von der Leyen

European Commission President Ursula von der Leyen announces
the EU will soon receive 50 million doses of the BioNTech/Pfizer vaccine, initially expected at the end of this year, as AstraZeneca and Johnson & John face setbacks over blood clot links.